Latest Content
Oncolytic Viruses: Mid-Year Landscape Review 2022
TPD: Mid-Year Landscape Review 2022
Cancer Vaccine: Mid-Year Landscape Review 2022
Webinars
Beacon Cancer Vaccine Webinar 2022
DDR Webinar 2022
TPD Webinar 2021
ADC
ASCO 2022: ADC Highlights and Insights
ADC ASCO Post-Conference Report 2022
New day for antibody-drug conjugates – Chemical & Engineering News
Adoptive Cell
Adoptive Cell: Mid-Year Landscape Review 2022
Adoptive Cell ASCO Post-Conference Report 2022
Adoptive Cell – Manufacturing Challenges & Considerations for Allogeneic Cell Therapy
Bispecific
ASCO 2022: Bispecific Highlights and Insights
Bispecific ASCO Post-Conference Report 2022
Bispecific ASCO Pre-Conference Planner 2022
DDR
DDR ASCO Post-Conference Report 2022
DDR ASCO Pre-Conference Planner 2022
DDR AACR Infographic 2022
Checkpoint
4-1BB Landscape Review: Shift Towards a Bispecific Therapeutics Approach
Checkpoint ASCO Post-Conference Report 2022
Checkpoint ASCO Pre-Conference Planner 2022
Cancer Vaccine
Cancer Vaccine: Mid-Year Landscape Review 2022
Cancer Vaccine ASCO Post-Conference Report 2022
Beacon Cancer Vaccine Webinar 2022
Cytokine
Cytokine ASCO Post-Conference Report 2022
Cytokine ASCO Pre-Conference Planner 2022
The Thriving Interleukin Therapies Landscape: Clinical and Preclinical Key Developments
Gene Therapy
Gene Therapy: Mid-Year Landscape Review 2022
Gene Therapy ASGCT Post-Conference Report 2022
Gene Therapy ASGCT Pre-Conference Planner 2022
RNA
The mRNA Landscape and Beyond Presentation
The Oligonucleotide Landscape and Beyond Presentation
RNA ASGCT Pre-Conference Planner 2022
Oncolytic Viruses
Oncolytic Viruses: Mid-Year Landscape Review 2022
Oncolytic Viruses ASCO Post-Conference Report 2022
Oncolytic Viruses – Vaccinia Virus Analysis
TPD
TPD: Mid-Year Landscape Review 2022
TPD ASCO Post-Conference Report 2022
TPD Beacon Podcast Ep.1
About Beacon Targeted Therapies
See how our clinical trials and drug database solutions in action
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
